Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918890 | Radiotherapy and Oncology | 2012 | 5 Pages |
Abstract
A new concept for urethra dose reduction is presented. The method relies on the use of a Ni-Ti stent as a fiducial marker combined with intensity modulated radiotherapy. Theoretical calculations suggest preserved tumour control.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jakob Borup Thomsen, Dennis Tideman Arp, Jesper Carl,